Omega Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Omega Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q3 2024.
  • Omega Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.72M, a 24.4% decline year-over-year.
  • Omega Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $8.48M, a 3.66% decline year-over-year.
  • Omega Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $8.79M, a 13.4% increase from 2022.
  • Omega Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.75M, a 143% increase from 2021.
  • Omega Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.18M, a 400% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $8.48M $1.72M -$557K -24.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $9.04M $1.21M -$965K -44.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $10M $3.43M +$1.21M +54.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $8.79M $2.11M -$9K -0.42% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $8.8M $2.28M +$307K +15.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $8.5M $2.18M +$124K +6.04% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $8.37M $2.22M +$618K +38.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $7.75M $2.12M +$940K +79.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $6.81M $1.97M +$850K +75.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $5.96M $2.05M +$1.37M +200% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $4.59M $1.6M +$1.41M +727% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $3.18M $1.18M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 $1.12M +$894K +390% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $685K +$578K +540% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $194K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q3 2020 $229K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $107K Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.